270 related articles for article (PubMed ID: 19565285)
1. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
[TBL] [Abstract][Full Text] [Related]
3. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
4. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
5. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
7. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
11. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
Zhang ZF; Ma JQ; Sun N; Zhang L
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
[TBL] [Abstract][Full Text] [Related]
12. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
[TBL] [Abstract][Full Text] [Related]
13. [Value of blood assay of tumor markers for detecting recurrence of colorectal cancer].
Pélissier E; Bosset JF; Meneveau N
Bull Cancer; 1994 Dec; 81(12):1050-6. PubMed ID: 7742592
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies.
Bielicki D; Karbowniczek M; Sulzyc-Bielicka V; Kładny J; Boer C; Marlicz K; Domagała W
Pol J Pathol; 1999; 50(2):77-81. PubMed ID: 10481530
[TBL] [Abstract][Full Text] [Related]
16. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
17. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
[TBL] [Abstract][Full Text] [Related]
18. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer.
Nakagoe T; Sawai T; Ayabe H; Nakazaki T; Ishikaw H; Hatano K; Kajiwara K; Miyashita K; Matsuo T; Nogawa T; Arisawa K
Anticancer Res; 2001; 21(4B):3031-6. PubMed ID: 11712806
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]